Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: INDICATIONS AND USAGE Hydrochlorothiazide is indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. US FDA label
Use: Hypertension, including renal parenchymal hypertension renalcarematters.com, reviewed
Kidney dosing: Imidapril (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Usual: 5 to 10 mg once daily (Singapore NDF).
- CrCl 30–59 mL/min
- Hypertension with kidney impairment: start 2.5 mg once daily and titrate (Singapore NDF). Monitor potassium and creatinine.
- CrCl 15–29 mL/min
- CrCl <30 mL/min (or serum creatinine above 3 mg/dL): use with care; consider halving the usual dose or extending the dosing interval. Start at 2.5 mg once daily in hypertension with kidney impairment (Singapore NDF). Monitor potassium and creatinine.
- CrCl <15 mL/min (not on dialysis)
- CrCl <30 mL/min (or serum creatinine above 3 mg/dL): use with care; consider halving the usual dose or extending the dosing interval. Start at 2.5 mg once daily in hypertension with kidney impairment (Singapore NDF). Monitor potassium and creatinine.
- Hemodialysis (intermittent)
- Hemodialysis with AN69 (polyacrylonitrile) membranes is contraindicated (anaphylactoid reactions). Dose as for CrCl <30 (half dose or longer interval); no dialysis-specific dosing given (Singapore NDF).
- Peritoneal dialysis
- Dose as for CrCl <30; no PD-specific data.
- CRRT
- No data; avoid starting ACE inhibitors in acute kidney injury.
- Dialyzable? Not stated.
- Monitoring Potassium and creatinine after starting and dose changes; blood pressure (excess hypotension); angioedema (Singapore NDF). Recheck creatinine and potassium after starting or increasing the dose; continue unless creatinine rises by more than 30% within 4 weeks, and investigate larger rises (renal artery stenosis, volume depletion, NSAIDs). Continue even when eGFR falls below 30 unless not tolerated (KDIGO 2024).
From the Imidapril monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Tablet: 10 mg/12.5 mg
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Hydrochlorothiazide + Imidapril as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
NORPLUSImidapril Hydrochloride + Hydrochlorothiazide | 10 mg/12.5 mg TabletAluminum Flex Foil x 10's Box of 100's | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, INC. | DRP-10045 | Sep 18, 2027 | |
VascorideImidapril Hydrochloride + Hydrochlorothiazide | 10 mg/12.5 mg TabletAluminum Flex Foil x 10's (Box of 50's) | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, INC. | DRP-11919 | Sep 12, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .